Virtue Capital Management, LLC Edwards Lifesciences Corp Transaction History

Virtue Capital Management, LLC

$477 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $96,017 - $107,419	-1,139 Reduced 16.14%	5,918 $546,000
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $22,705 - $29,910	-313 Reduced 4.25%	7,057 $674,000
Q4 2023 Feb 15, 2024	BUY	$61.71 - $77.76 $14,933 - $18,817	242 Added 3.4%	7,370 $561,000
Q2 2023 Jul 18, 2023	SELL	$81.41 - $94.33 $22,469 - $26,035	-276 Reduced 3.73%	7,128 $672,000
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $38,318 - $43,607	-516 Reduced 6.52%	7,404 $612,000
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $540,936 - $692,524	7,920 New	7,920 $590,000
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $2.01 Million - $2.98 Million	-23,249 Reduced 91.3%	2,215 $211,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $283,142 - $356,400	-2,777 Reduced 9.83%	25,464 $3 Million
Q4 2021 Jan 24, 2022	BUY	$106.37 - $130.68 $171,468 - $210,656	1,612 Added 6.05%	28,241 $3.66 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $57,629 - $68,740	-560 Reduced 2.06%	26,629 $3.02 Million
Q2 2021 Jul 15, 2021	BUY	$83.84 - $104.76 $104,129 - $130,111	1,242 Added 4.79%	27,189 $2.82 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $41,857 - $48,236	532 Added 2.09%	25,947 $2.17 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $190,480 - $242,398	-2,657 Reduced 9.46%	25,415 $2.32 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $91,244 - $118,743	1,358 Added 5.08%	28,072 $2.24 Million
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $1.54 Million - $2.06 Million	26,714 New	26,714 $1.85 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $373,578 - $577,368	-7,128 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $132,143 - $151,291	1,843 Added 34.87%	7,128 $1.66 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $112,513 - $137,886	1,828 Added 52.88%	5,285 $1.16 Million
Q2 2019 Nov 12, 2019	BUY	$55.74 - $64.41 $192,693 - $222,665	3,457 New	3,457 $639,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $594 - $718	-14 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $473 - $551	14	14 $2,000

Others Institutions Holding EW

# of Institutions

1,352

Shares Held

469M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.45 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.63 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.24 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.87 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$962 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.

Account